Patients & Physicians

Turning our knowledge of cellular metabolism
into new medicines that improve the lives of patients

At Imbria, our mission is to translate our understanding of cellular metabolism into medicines that improve the lives of patients with limited or inadequate treatment options. Our goal is to be the leading global biopharmaceutical company focused on novel treatment of diseases and disorders related to energy metabolism.

We are currently advancing treatments that can help enhance or restore energy-related cellular functions necessary to thrive. Diseases and disorders we are currently focused on include:

Refractory Angina

Angina is chest pain or discomfort that can feel like a heart attack. Refractory angina is chronic angina that persists despite treatment with available therapies.

Heart Failure

Heart Failure is a chronic, progressive condition in which the heart is unable to keep up with its workload. In Heart Failure, a weakened heart may not adequately deliver blood throughout the body.

Propionic Acidemia

Propionic Acidemia is a rare disorder where the body lacks sufficient activity of an enzyme necessary for all cells to consistently produce the amounts of energy they require.